Review
Published on 22 Apr 2022
Novel Therapeutics for Anthracycline Induced Cardiotoxicity
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.863314
- 12,483 views
- 29 citations
Type at least 3 characters
358 articles
Review
Published on 21 Apr 2022
Genetics of Anthracycline-Associated Cardiotoxicity
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.867873
- 5,488 views
- 18 citations
Review
Published on 15 Apr 2022
Cardio-Oncology Rehabilitation and Telehealth: Rationale for Future Integration in Supportive Care of Cancer Survivors
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.858334
- 6,708 views
- 25 citations
Review
Published on 15 Apr 2022
Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.847012
- 23,215 views
- 94 citations
Original Research
Published on 15 Apr 2022
Anti-cancer Drugs Associated Atrial Fibrillation—An Analysis of Real-World Pharmacovigilance Data
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.739044
- 7,774 views
- 22 citations
Systematic Review
Published on 14 Apr 2022
Higher Mortality Associated With New-Onset Atrial Fibrillation in Cancer Patients: A Systematic Review and Meta-Analysis
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.867002
- 3,973 views
- 14 citations
Original Research
Published on 14 Apr 2022
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.867867
- 2,973 views
- 11 citations
Original Research
Published on 13 Apr 2022
Long-Term Risk of Death From Heart Disease Among Breast Cancer Patients
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.784409
- 5,678 views
- 11 citations
Original Research
Published on 11 Apr 2022
Aberrant Expression of Cardiac Troponin-T in Lung Cancer Tissues in Association With Pathological Severity
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.833649
- 4,036 views
- 5 citations
Original Research
Published on 07 Apr 2022
Coronary Atherosclerotic Disease and Cancer: Risk Factors and Interrelation
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.821267
- 4,033 views
- 12 citations
Case Report
Published on 04 Apr 2022
Case Report: Systemic Amyloidosis Involving the Heart and Skeletal Muscle
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.816236
- 4,491 views
Original Research
Published on 25 Mar 2022
Divergent Cardiac Effects of Angiotensin II and Isoproterenol Following Juvenile Exposure to Doxorubicin
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.742193
- 4,300 views
- 6 citations
Original Research
Published on 23 Mar 2022
Alteration of N6-Methyladenosine mRNA Methylation in a Human Stem Cell-Derived Cardiomyocyte Model of Tyrosine Kinase Inhibitor-Induced Cardiotoxicity
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.849175
- 4,215 views
- 10 citations
Case Report
Published on 21 Mar 2022
Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.848091
- 4,156 views
- 13 citations
Original Research
Published on 21 Mar 2022
Early Change in Area Strain Detected by 3D Speckle Tracking Is Associated With Subsequent Cardiotoxicity in Patients Treated With Low Doses of Anthracyclines
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.842532
- 2,583 views
- 9 citations
Systematic Review
Published on 17 Mar 2022
Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.727487
- 14,372 views
- 47 citations